Lufax shares plunge 40% on Hong Kong resumption after 20-month suspension
Lufax Holding resumed trading on the Hong Kong Stock Exchange on September 24, 2026, after a nearly 20-month suspension triggered by a dispute with former auditor PwC over suspected related-party transactions. The stock closed at HK$6.45, down 40.83%. The company met all six resumption conditions, including an independent investigation that found loan funds were used to compensate retail investors. Lufax reported 2025 revenue of 27.1 billion yuan and total assets of 202.7 billion yuan as of June 2026.
Reference imageEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Common ground
- Lufax's 20-month suspension and resumption involved serious issues like a PwC resignation and suspected related-party transactions.
- The company met HKEX's six conditions for resumption, including an independent investigation and governance overhaul.
- Lufax is pivoting from its core P2P lending business to consumer finance, but this segment is still small.
- The 40% drop in Hong Kong shares on resumption day reflected accumulated selling pressure after a long suspension.
- The U.S. market's 6% rise on resumption day showed that some investors saw the cleanup as a positive step.
Points of contention
- Eastern Agent sees the resumption as a regulatory success story, while Regional Agent calls it a human tragedy and Neutral Agent views it as a managed decline.
- Regional Agent insists retail investors were harmed, but Eastern and Neutral Agents say there's no clear evidence of who lost money or how much.
- Eastern Agent argues the 40% Hong Kong drop was just mechanical rebalancing, while Regional and Neutral Agents see it as a market vote of no confidence.
- Regional Agent frames the situation as a colonial legacy of extraction, but Eastern and Neutral Agents reject this as ideological or irrelevant.
- Neutral Agent says Lufax is a zombie company kept alive by its parent, while Eastern Agent calls it a company in transition with a viable future.
Blind spots
- No one provided concrete data on how many retail investors were affected or what their actual losses were.
- The debate ignored whether Lufax's business model of lending to subprime borrowers is sustainable in a slowing economy.
- There was little discussion of how Lufax's competitors in China are handling similar regulatory and market pressures.
- The long-term impact of the 20-month suspension on Lufax's brand trust and customer base was not explored.
WorldAttention’s read
The Lufax case shows a company that went through a tough regulatory cleanup after serious problems, but opinions differ sharply on what it means. Eastern Agent sees it as proof that China's system works and the company is on the right track, while Regional Agent focuses on the human cost and argues the system protected big investors over ordinary people. Neutral Agent cuts through both by pointing out the math doesn't add up—the core loan business is shrinking faster than the new consumer finance arm can grow, making Lufax look like a company in managed decline rather than a turnaround. All sides agree the suspension was a major red flag and the resumption was a mixed signal, but they can't agree on whether this is a success story, a cautionary tale, or just a zombie company kept alive by its parent. The biggest missing piece is clear evidence about who actually got hurt and how badly, which leaves the debate stuck in competing narratives rather than hard facts.
Reporting timeline
Lufax Holding (LU.US) Extends Rally, Surges About 18% in Two Days on HKEX Resumption
Lufax Holding (LU.US) continued its upward trend on Thursday, rising over 11% as of press time, bringing its two-day gain to approximately 18%. The stock surge follows the company's full compliance with the Hong Kong Stock Exchange's (HKEX) resumption guidance. HKEX had previously listed six conditions for Lufax's resumption, covering independent investigation, financial restatement, management integrity, internal controls, continued listing eligibility, and information disclosure—all of which have now been fulfilled. Trading on the HKEX resumed at 9:00 AM on September 24, 2026. During the suspension period, Lufax's core retail credit empowerment business and consumer finance business maintained normal operations. The company reported total revenue of approximately 27.1 billion yuan for fiscal year 2025 and total assets of approximately 202.7 billion yuan as of June 30, 2026.
Lufax Holding Resumes Hong Kong Trading After 20-Month Suspension, Market Cap at HK$11.2 Billion
Lufax Holding (stock code: 06623.HK) resumed trading on the Hong Kong Stock Exchange on September 24 after a 20-month suspension that began on January 28, 2025. The stock opened at HK$8.60 and closed at HK$6.45, a 40.83% decline from its last trading day, giving the company a market capitalization of HK$11.2 billion. The resumption followed the fulfillment of all resumption guidelines. An independent investigation revealed that between June 2017 and January 2023, Lufax provided a total of 3.84 billion yuan in loans to Decheng Investment, which were used for various purposes including establishing Zhongshi, acquiring Jiayun Huaao, and compensating retail investors. Additionally, employee expense reimbursements totaling approximately 77.9 million yuan were identified between October 2021 and July 2025. Lufax reported 2025 revenue of 27.1 billion yuan, up 10.7% year-on-year, with a net loss of 1.7 billion yuan, narrowing 52.78% from the prior year. For the first half of 2026, revenue was 12.489 billion yuan, down 11.3%, with a net loss of 694 million yuan. Management changes included Ye Diqi being appointed chairman in April 2025, replacing Zhao Rongshi, and Ji Xiang becoming CEO.
Read sourceLufax shares plunge 40% on Hong Kong resumption after 600-day suspension
Lufax Holding, a subsidiary of China's Ping An Insurance Group, resumed trading on the Hong Kong Stock Exchange on September 24, 2026, after a suspension lasting over 600 days since January 28, 2025. The stock closed at HK$6.45, down 40.83% on the first day. The resumption followed Lufax's announcement on September 23 that it had fully satisfied all six conditions set by the exchange, including independent investigation, financial restatement, management integrity, internal controls, continuing listing eligibility, and information disclosure. Meanwhile, Lufax's U.S.-listed shares, which remained trading throughout the suspension, rose 6.09% to $1.22 per ADS on September 23. The company's 2026 interim report showed total revenue fell to 124.89 billion yuan from 140.84 billion yuan a year earlier, while net loss widened to 6.94 billion yuan from 5.19 billion yuan. Loan balances declined 13.5% year-on-year to 1,673 billion yuan, though consumer finance loans grew 19.9% to 654 billion yuan. Asset quality improved, with the C-M3 migration rate dropping to 1.0% and the 30-day-plus delinquency rate falling to 5.8%. Lufax said uncertainties have been largely eliminated and will focus on consumer finance, AI tools, and customer segmentation.
Read sourceShow 6 older updatesHide older updates
Lufax Holding resumes Hong Kong trading after nearly 20-month suspension
Lufax Holding (HK06623) resumed trading on the Hong Kong Stock Exchange on September 24, 2026, after a nearly 20-month suspension that began on January 28, 2025. The suspension was triggered by a disagreement with former auditor PwC over 'suspected related-party transactions,' leading to an independent forensic investigation and the appointment of Ernst & Young as successor auditor. The Hong Kong exchange had set six resumption conditions, all of which have now been fulfilled. The independent investigation, led by law firm Morgan Lewis with forensic support from AlixPartners, found that loan funds were primarily used to compensate retail investors of financial products promoted through Lufax's platform. Ernst & Young completed re-audits for 2022-2025 and issued unqualified opinions for 2024 and 2025. Deloitte confirmed improved internal controls. Lufax's board now consists of one executive director and five independent non-executive directors, with a new chief compliance officer. Parent company Ping An Group issued an irrevocable commitment to maintain Lufax's independent governance. Lufax reported 2025 total revenue of approximately 27.1 billion yuan and total assets of about 202.7 billion yuan as of June 2026. The company's U.S. shares rose about 6% on the announcement.
Read sourceLufax Holding resumes trading on Hong Kong Stock Exchange after nearly 20-month suspension
Lufax Holding (HK06623) resumed trading on the Hong Kong Stock Exchange on September 24, 2026, after a nearly 20-month suspension that began on January 28, 2025. The suspension was triggered by a disagreement with former auditor PwC over 'suspected related-party transactions,' leading to the appointment of Ernst & Young as successor auditor and an independent forensic investigation. The Hong Kong Stock Exchange had set six resumption conditions, including independent investigation, financial restatement, management integrity, internal controls, continued listing eligibility, and information disclosure. Lufax stated all conditions have been fulfilled. The company's US-listed shares (LU.US) rose over 8% intraday following the announcement. Lufax's business model includes retail credit facilitation for small business owners and consumer finance services. In the first half of 2026, the company reported total new loans of 99.9 billion yuan, with consumer finance loans increasing to 66.2 billion yuan. The company stated that uncertainties have been largely eliminated and it will face capital market scrutiny with improved governance and financial structure.
Read sourceLufax Holding meets all resumption conditions, to resume Hong Kong trading on September 24
Lufax Holding Ltd (6623.HK, LU.US) announced on September 23 evening that it has fully satisfied all six resumption guidance conditions set by the Hong Kong Stock Exchange, paving the way for its shares to resume trading on September 24, 2026, after a nearly 20-month suspension since January 28, 2025. The conditions included independent investigations, financial restatements, management integrity, internal controls, and continuous listing eligibility. The company's U.S. shares rose over 8% on the news. During the suspension, Lufax maintained core retail credit and consumer finance operations, reporting 2025 total revenue of approximately 271 billion yuan and total assets of 202.7 billion yuan as of June 30, 2026. The company's consumer finance loan balance grew 19.9% year-on-year to 65.4 billion yuan, while asset quality improved with the C-M3 migration rate dropping to 1.0% and the 30-day delinquency rate falling to 5.8%. Cost-cutting measures reduced total expenses by 3.1% year-on-year in the first half of 2026, narrowing net losses. The company plans to focus on consumer finance, AI tools, and customer expansion going forward.
Read sourceLufax Holding to Resume Hong Kong Trading on Sept 24 After 20-Month Suspension
Lufax Holding Ltd. announced on September 22 that it has fully complied with the Hong Kong Stock Exchange's resumption guidelines, and its shares will resume trading on September 24, 2026, after a nearly 20-month suspension since January 28, 2025. The announcement caused its US-listed shares (LU.US) to rise over 8% intraday. The company met six conditions set by the exchange, including completing an independent investigation into certain transactions led by law firm Morgan Lewis and forensic support from AlixPartners, restating financial statements audited by Ernst & Young, and implementing internal control improvements verified by Deloitte. Lufax reported total revenue of approximately 271 billion yuan in 2025 and total assets of about 202.7 billion yuan as of June 30, 2026. Its consumer finance loan balance grew 19.9% year-over-year to 65.4 billion yuan. The company's asset quality improved, with the 30-day delinquency rate falling to 5.8%. Lufax plans to focus on consumer finance, AI tools like 'digital avatars', and expanding its customer base among self-employed individuals and salaried workers.
Read sourceLufax Holding resumes trading on Hong Kong Stock Exchange after nearly 20-month suspension
Lufax Holding (Lufax) resumed trading on the Hong Kong Stock Exchange on September 24, 2026, after a nearly 20-month suspension that began on January 28, 2025. The suspension was triggered by a disagreement with former auditor PwC over 'suspected related-party transactions,' leading to the appointment of Ernst & Young as successor auditor and an independent forensic investigation. The Hong Kong Stock Exchange had set six resumption conditions, including independent investigation, financial restatement, management integrity, internal controls, continued listing eligibility, and information disclosure. Lufax stated all conditions have been fulfilled. The independent investigation, led by international law firm Morgan Lewis with forensic support from AlixPartners, found that loan funds were primarily used to compensate retail investors in financial products promoted through Lufax's platform. Ernst & Young completed re-audits of financial statements from 2022 to 2025, issuing unqualified audit opinions for 2024 and 2025. Deloitte conducted an internal control review, confirming Lufax has established a compliant internal control system. Management and board have been restructured, with no current executives or directors involved in the investigated transactions. Ping An Group, the controlling shareholder, issued an irrevocable commitment to maintain Lufax's independent governance. Lufax reported total revenue of approximately 27.1 billion yuan in 2025 and total assets of about 202.7 billion yuan as of June 30, 2026. The company's U.S. shares rose about 6% following the announcement.
Read sourceLufax shares plunge 40% on Hong Kong resumption after 600-day suspension
Lufax Holding, a subsidiary of China's Ping An Group, saw its Hong Kong-listed shares drop 40.83% to HK$6.45 on their first trading day after a suspension lasting over 600 days. The resumption followed the company's announcement on September 23, 2026, that it had fully complied with all six resumption conditions set by the Hong Kong Stock Exchange, covering independent investigation, financial restatement, management integrity, internal controls, continued listing eligibility, and information disclosure. In contrast, Lufax's U.S.-listed shares rose 6.09% to $1.22 per ADS on the same day. The company's 2026 interim report showed total revenue fell to 124.89 billion yuan from 140.84 billion yuan a year earlier, while net loss widened to 6.94 billion yuan from 5.19 billion yuan. Loan balances declined 13.5% year-on-year to 1,673 billion yuan, though consumer finance loans grew 19.9% to 654 billion yuan. Asset quality improved, with the C-M3 migration rate dropping to 1.0% and the 30-day-plus delinquency rate falling to 5.8%. Lufax stated that uncertainties have been largely eliminated and will focus on consumer finance, AI tools, and customer expansion.
Read source